Pierantonio Russo, FCCP, FAAP, STS | Corporate Chief Medical Officer
EVERSANA

Pierantonio Russo, FCCP, FAAP, STS, Corporate Chief Medical Officer, EVERSANA

Dr. Russo serves as EVERSANA’s Chief Medical Officer.  He is responsible for ensuring the highest levels of quality and data integrity in the design and delivery of projects that require the translation of clinical, population medicine and health economic knowledge into actionable analyses across all programs. A cardiac thoracic and transplant surgeon, he began his career at the Mayo Clinic, and then served in clinical leadership roles at several academic hospitals including Temple University/St Christopher’s Hospital, Philadelphia and the University of Missouri. He holds a Certificate in Health Care Innovation-Health and Health Care Administration Management from the University of Pennsylvania-Philadelphia and a Certificate in Digital Medicine (Node.Health).  He is a member of the American Heart Association and has served as a lecturer in population medicine at the Harvard Medical School.

Appearances:



Day 2 - World Orphan Drug Congress USA 2025 @ 11:00

Panel: Validation of a machine learning predictive model for the identification of APDS patients

This presentation showcases innovative methods validated against the newly assigned ICD-10 code for Activated PI3K Delta Syndrome.

Sponsored by EVERSANA.

last published: 24/Apr/25 11:35 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

Connect with us

 
 
 
 

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Kaylee Nguyen
kaylee.nguyen@terrapinn.com
 

 

 

 

Marketing & Press

 
 

Kaylie Brogan
kaylie.brogan@terrapinn.com